ArticleOncology research2026

Factors Affecting the Efficacy and Safety of First-Line Anti-PD-1 Therapy in Advanced Non-Small Cell Lung Cancer.

Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.